145 related articles for article (PubMed ID: 31356956)
21. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery.
Jose S; Anju SS; Cinu TA; Aleykutty NA; Thomas S; Souto EB
Int J Pharm; 2014 Oct; 474(1-2):6-13. PubMed ID: 25102112
[TBL] [Abstract][Full Text] [Related]
22. Dissolution improvement of high drug-loaded solid dispersion.
Okonogi S; Puttipipatkhachorn S
AAPS PharmSciTech; 2006 Jun; 7(2):E52. PubMed ID: 16796369
[TBL] [Abstract][Full Text] [Related]
23. Preparation and cytotoxicity of 2-methoxyestradiol-loaded solid lipid nanoparticles.
Guo X; Xing Y; Mei Q; Zhang H; Zhang Z; Cui F
Anticancer Drugs; 2012 Feb; 23(2):185-90. PubMed ID: 22027535
[TBL] [Abstract][Full Text] [Related]
24. Cellular uptake of coumarin-6 as a model drug loaded in solid lipid nanoparticles.
Rivolta I; Panariti A; Lettiero B; Sesana S; Gasco P; Gasco MR; Masserini M; Miserocchi G
J Physiol Pharmacol; 2011 Feb; 62(1):45-53. PubMed ID: 21451209
[TBL] [Abstract][Full Text] [Related]
25. Improved corneal bioavailability of ofloxacin: biodegradable microsphere-loaded ion-activated in situ gel delivery system.
Sayed EG; Hussein AK; Khaled KA; Ahmed OA
Drug Des Devel Ther; 2015; 9():1427-35. PubMed ID: 25792803
[TBL] [Abstract][Full Text] [Related]
26. Nanostructured lipid carriers containing chitosan or sodium alginate for co-encapsulation of antioxidants and an antimicrobial agent for potential application in wound healing.
Costa-Fernandez S; Matos JKR; Scheunemann GS; Salata GC; Chorilli M; Watanabe IS; de Araujo GLB; Santos MF; Ishida K; Lopes LB
Int J Biol Macromol; 2021 Jul; 183():668-680. PubMed ID: 33930450
[TBL] [Abstract][Full Text] [Related]
27. New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation.
Rosière R; Van Woensel M; Gelbcke M; Mathieu V; Hecq J; Mathivet T; Vermeersch M; Van Antwerpen P; Amighi K; Wauthoz N
Mol Pharm; 2018 Mar; 15(3):899-910. PubMed ID: 29341619
[TBL] [Abstract][Full Text] [Related]
28. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer.
Wang F; Li L; Liu B; Chen Z; Li C
Biomed Pharmacother; 2017 Feb; 86():595-604. PubMed ID: 28027535
[TBL] [Abstract][Full Text] [Related]
29. Development and in vivo evaluation of an innovative "Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles" formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics.
Cirri M; Mennini N; Maestrelli F; Mura P; Ghelardini C; Di Cesare Mannelli L
Int J Pharm; 2017 Apr; 521(1-2):73-83. PubMed ID: 28229944
[TBL] [Abstract][Full Text] [Related]
30. Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats.
Pawar H; Surapaneni SK; Tikoo K; Singh C; Burman R; Gill MS; Suresh S
Drug Deliv; 2016 May; 23(4):1453-68. PubMed ID: 26878325
[TBL] [Abstract][Full Text] [Related]
31. Ultra-small lipid-dendrimer hybrid nanoparticles as a promising strategy for antibiotic delivery: In vitro and in silico studies.
Sonawane SJ; Kalhapure RS; Rambharose S; Mocktar C; Vepuri SB; Soliman M; Govender T
Int J Pharm; 2016 May; 504(1-2):1-10. PubMed ID: 26992817
[TBL] [Abstract][Full Text] [Related]
32. Roxithromycin-loaded lipid nanoparticles for follicular targeting.
Wosicka-Frąckowiak H; Cal K; Stefanowska J; Główka E; Nowacka M; Struck-Lewicka W; Govedarica B; Pasikowska M; Dębowska R; Jesionowski T; Srčič S; Markuszewski MJ
Int J Pharm; 2015 Nov; 495(2):807-15. PubMed ID: 26456292
[TBL] [Abstract][Full Text] [Related]
33. The use of solid lipid nanoparticles for sustained drug release.
Attama AA; Umeyor CE
Ther Deliv; 2015; 6(6):669-84. PubMed ID: 26149784
[TBL] [Abstract][Full Text] [Related]
34. Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles.
Silva AC; Kumar A; Wild W; Ferreira D; Santos D; Forbes B
Int J Pharm; 2012 Oct; 436(1-2):798-805. PubMed ID: 22867992
[TBL] [Abstract][Full Text] [Related]
35. Mucoadhesive chitosan films as a potential ocular delivery system for ofloxacin: preliminary in vitro studies.
de Oliveira Fulgêncio G; Viana FA; Silva RO; Lobato FC; Ribeiro RR; Fanca JR; Byrro RM; Faraco AA; da Silva Cunha-Júnior A
Vet Ophthalmol; 2014 Mar; 17(2):150-5. PubMed ID: 24428388
[TBL] [Abstract][Full Text] [Related]
36. Controlled release and reversal of multidrug resistance by co-encapsulation of paclitaxel and verapamil in solid lipid nanoparticles.
Baek JS; Cho CW
Int J Pharm; 2015 Jan; 478(2):617-24. PubMed ID: 25510604
[TBL] [Abstract][Full Text] [Related]
37. Amikacin loaded PLGA nanoparticles against Pseudomonas aeruginosa.
Sabaeifard P; Abdi-Ali A; Soudi MR; Gamazo C; Irache JM
Eur J Pharm Sci; 2016 Oct; 93():392-8. PubMed ID: 27575877
[TBL] [Abstract][Full Text] [Related]
38. Non-lamellar lyotropic liquid crystalline nanoparticles enhance the antibacterial effects of rifampicin against Staphylococcus aureus.
Tran N; Hocquet M; Eon B; Sangwan P; Ratcliffe J; Hinton TM; White J; Ozcelik B; Reynolds NP; Muir BW
J Colloid Interface Sci; 2018 Jun; 519():107-118. PubMed ID: 29486430
[TBL] [Abstract][Full Text] [Related]
39. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines.
Doktorovova S; Souto EB; Silva AM
Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267
[TBL] [Abstract][Full Text] [Related]
40. Eugenol-chitosan nanoemulsions by ultrasound-mediated emulsification: Formulation, characterization and antimicrobial activity.
Shao Y; Wu C; Wu T; Li Y; Chen S; Yuan C; Hu Y
Carbohydr Polym; 2018 Aug; 193():144-152. PubMed ID: 29773366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
